Abstract Context: National guidelines recommend that patients with chronic non-cancer pain prescribed long-term opioid therapy (LTOT) undergo periodic urine drug testing (UDT), yet little evidence supports the utility of this approach. Given the wide variation in test utilization and interpretation, it is important to understand factors associated with UDT. Objective: To identify patient and prescriber factors associated with UDT in primary care patients prescribed LTOT.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile